A discussion of Sharon Angell’s two-part article from the New York Review of Books, in which she discusses recent volumes by Robert Whitaker, Irving Kirsch and Daniel Carlat addressing the chemical imbalance theory of mental illness, along with the influence of Big Pharma upon the psychiatric profession.